| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0714e2b82fd433474c92ad182e6b71c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3ef57ca558f5e4475acd8354b4354e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bf8af06102ee78b464a9cd79b9561bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7008a05f779bbe34dd163ad578fff90e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate |
2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ac7279fbcb35cf0458c220f9b4d890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7312edfb98493abc36ef5abf988e91d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283cd6f0a85168110672521519906e8c |
| publicationDate |
2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8398969-B2 |
| titleOfInvention |
Compositions and methods for the treatment of viral hepatitis |
| abstract |
The present invention discloses a novel apathogenic viral strain useful in the treatment of viral hepatitis infections. The preferred viral strain of Infectious Bursal Disease Virus (IBDV) is specifically characterized in terms of structure and biological activities. The invention also provides recombinant IBDV viral vectors for the inclusion of exogenous nucleic acid sequences enhancing the viral replication inhibitory effect of the virus of the invention. Preferably, the viral vector comprises a nucleic acid sequence encoding a cytokine. A method of treating viral hepatitis in a host comprising administering an anti-hepatitis effective amount of the IBDV strain of the present invention also provided. |
| priorityDate |
2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |